MedPath

Effect of Proton Pump Inhibitors (pantoprazol) on Hypomagnesaemia

Phase 2
Conditions
Atherosclerotic heart disease.
Coronary (artery): atheroma atherosclerosis disease sclerosis
Registration Number
IRCT201511088384N5
Lead Sponsor
Mashhad university of medical sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
380
Inclusion Criteria

??????? ?????? ????? CABG ?? ??? off-pump ???? ?????? ?????? ??. ???????? ???? ?? ?????? ???? ??? ????? ?? ????: ??? ????? ?????? ??????? ??? ????? ????? ???? ??? ??????? ???????? ?? ?? ?? ????? ??? ????? CABG ?? ??? on-pump ???? ???????? ????? ?????? ?????? ??? ???? ???? ???????? ??? ????????? ??????? ???? ? ?? ??????? single kidney? ?????? ?? ???? ???? ???? ??? ? CPR ?????? ??? ???? ?????CABG ???????? ??????? ????? ?? ??? ????? ????? ????? ?????? ?? ??????? ???? ??????? ? ?? ???? ????? ?????? ?????? ?? ??????? ?? ????? ??????? ????? ?? ??????? ???? ?? EF< 35%? ???? ?????? ?????? ???? ??? ???? ????? ???? ??????? ?? ??????? ????? CABG ????? ????? ?????? ?????????? ( ???? ?? ???? ?????/ ????? ) ??? ?? ???? ??????? ??????? ?? ???? ?????? ?????? ????? ????? QT ??????? QT ?????? ??????? ? ????? ??????? ?? ????? ??????? ???? ? ??? ????? ?? ?????????? ? H2 ?????.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hypomagnesaemia. Timepoint: Before/ after surgery. Method of measurement: serum.
Secondary Outcome Measures
NameTimeMethod
Arrhythmia. Timepoint: After surgery. Method of measurement: ECG.
© Copyright 2025. All Rights Reserved by MedPath